Literature DB >> 9822744

Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth.

G Paglini1, G Pigino, P Kunda, G Morfini, R Maccioni, S Quiroga, A Ferreira, A Cáceres.   

Abstract

Cultures of cerebellar macroneurons were used to study the pattern of expression, subcellular localization, and function of the neuronal cdk5 activator p35 during laminin-enhanced axonal growth. The results obtained indicate that laminin, an extracellular matrix molecule capable of selectively stimulating axonal extension and promoting MAP1B phosphorylation at a proline-directed protein kinase epitope, selectively stimulates p35 expression, increases its association with the subcortical cytoskeleton, and accelerates its redistribution to the axonal growth cones. Besides, suppression of p35, but not of a highly related isoform designated as p39, by antisense oligonucleotide treatment selectively reduces cdk5 activity, laminin-enhanced axonal elongation, and MAP1b phosphorylation. Taken collectively, the present results suggest that cdk5/p35 may serve as an important regulatory linker between environmental signals (e.g., laminin) and constituents of the intracellular machinery (e.g., MAP1B) involved in axonal elongation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822744      PMCID: PMC6793278     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  58 in total

1.  Variable membrane glycoproteins in different growth cone populations.

Authors:  H N Li; S Quiroga; K H Pfenninger
Journal:  J Neurosci       Date:  1992-06       Impact factor: 6.167

2.  The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons.

Authors:  A Caceres; S Potrebic; K S Kosik
Journal:  J Neurosci       Date:  1991-06       Impact factor: 6.167

3.  Laminin stimulates expression of two mitochondrial proteins during neurite outgrowth.

Authors:  B S Weeks; P Burbelo; M Jucker; M A Weiner; E Roque; H K Kleinman
Journal:  Int J Dev Neurosci       Date:  1996-06       Impact factor: 2.457

Review 4.  Integrins: emerging paradigms of signal transduction.

Authors:  M A Schwartz; M D Schaller; M H Ginsberg
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

5.  Dephosphorylated but not phosphorylated microtubule associated protein MAP1B binds to microfilaments.

Authors:  B Pedrotti; K Islam
Journal:  FEBS Lett       Date:  1996-06-17       Impact factor: 4.124

6.  Altered microtubule organization in small-calibre axons of mice lacking tau protein.

Authors:  A Harada; K Oguchi; S Okabe; J Kuno; S Terada; T Ohshima; R Sato-Yoshitake; Y Takei; T Noda; N Hirokawa
Journal:  Nature       Date:  1994-06-09       Impact factor: 49.962

7.  Microtubule-associated protein 1b (MAP1b) is concentrated in the distal region of growing axons.

Authors:  M M Black; T Slaughter; I Fischer
Journal:  J Neurosci       Date:  1994-02       Impact factor: 6.167

8.  Estrogen-enhanced neurite growth: evidence for a selective induction of Tau and stable microtubules.

Authors:  A Ferreira; A Caceres
Journal:  J Neurosci       Date:  1991-02       Impact factor: 6.167

Review 9.  Role of microtubule-associated proteins in the control of microtubule assembly.

Authors:  R B Maccioni; V Cambiazo
Journal:  Physiol Rev       Date:  1995-10       Impact factor: 37.312

10.  MAP-1B/TAU functional redundancy during laminin-enhanced axonal growth.

Authors:  M C DiTella; F Feiguin; N Carri; K S Kosik; A Cáceres
Journal:  J Cell Sci       Date:  1996-02       Impact factor: 5.285

View more
  46 in total

1.  Evidence for the involvement of Tiam1 in axon formation.

Authors:  P Kunda; G Paglini; S Quiroga; K Kosik; A Caceres
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

Review 2.  Tau protein function in axonal formation.

Authors:  G Paglini; L Peris; F Mascotti; S Quiroga; A Caceres
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

3.  Differential association of tau with subsets of microtubules containing posttranslationally-modified tubulin variants in neuroblastoma cells.

Authors:  L Saragoni; P Hernández; R B Maccioni
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

4.  Evidence for the role of MAP1B in axon formation.

Authors:  C Gonzalez-Billault; J Avila; A Cáceres
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

5.  The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic.

Authors:  G Paglini; L Peris; J Diez-Guerra; S Quiroga; A Cáceres
Journal:  EMBO Rep       Date:  2001-11-21       Impact factor: 8.807

6.  Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation.

Authors:  B S Li; L Zhang; J Gu; N D Amin; H C Pant
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

7.  Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons.

Authors:  Timothy M E Scales; Shen Lin; Michaela Kraus; Robert G Goold; Phillip R Gordon-Weeks
Journal:  J Cell Sci       Date:  2009-06-23       Impact factor: 5.285

Review 8.  Cdk5: mediator of neuronal development, death and the response to DNA damage.

Authors:  Jinqiu Zhu; Wenming Li; Zixu Mao
Journal:  Mech Ageing Dev       Date:  2011-05-11       Impact factor: 5.432

9.  PHF-like tau phosphorylation in mammalian hibernation is not associated with p25-formation.

Authors:  Jens Thorsten Stieler; Torsten Bullmann; Franziska Kohl; Brian M Barnes; Thomas Arendt
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

10.  Identification of non-muscle myosin heavy chain as a substrate for Cdk5 and tool for drug screening.

Authors:  Anne Jämsä; Karin Agerman; Ann-Cathrin Radesäter; Jan Ottervald; Jonas Malmström; Gösta Hiller; Gang Liu; Mervi Vasänge
Journal:  J Biomed Sci       Date:  2009-06-17       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.